CWHM-1552

Research use only, not for human use.

CWHM-1552 is an effective Plasmodium falciparum inhibitor. For the 3D7 and Dd2 strains, the IC50s are 51 nM and 53 nM.

CWHM-1552 is an orally efficacious inhibitor of P. falciparum with IC50s of 51 nM and 53 nM for 3D7 and Dd2 strain, respectively.

——

CWHM-1552 (Compound (-)-32a) (orally; 3-30 mg/kg/day for 4 days) inhibits parasitemia at 99.9% at 30 mg/kg/day and 94% at 10 mg/kg/day. CWHM-1552 (i.v. administration; 2 mg/kg/day for 48 hours) has respectable half-lives (2.7 h) and low clearance in mice. CWHM-1552 has good pharmacokinetic properties and oral efficacy in a mouse model of malaria. CWHM-1552 has an in vivo ED90 of <10 mg/kg/day and ED99 of 30 mg/kg/day, respectively. Animal Model:P. chabaudi ASS infected Mice Dosage:3, 10, 30 mg/kg Administration:Orally; daily for 4 days Result:Inhibited parasitemia at 99.9% at 30 mg/kg/day and 94% at 10 mg/kg/day.Animal Model: Male KM miceDosage:2 mg/kg Administration:I.v. administration; dailyResult:Had respectable half-lives (2.7 h) and low clearance in mice.

——

Microbiology/Virology

Parasite

Parasite

——

——

2368253-58-9

387.47

C22H27F2N3O

>98% (HPLC)

——

N(C(CC1=CC=C(N(C)C)C=C1)=O)[C@H]2[C@@H](CNC2)C3=CC=C(C(C)(F)F)C=C3

——

(-20℃)

With Ice Pack

≥ 2 years